These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 18026200

  • 1. Burden of illness of neovascular age-related macular degeneration in Canada.
    Cruess A, Zlateva G, Xu X, Rochon S.
    Can J Ophthalmol; 2007 Dec; 42(6):836-43. PubMed ID: 18026200
    [Abstract] [Full Text] [Related]

  • 2. Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.
    Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monès J, Xu X, Zlateva G, Buggage R, Conlon J, Goss TF.
    Arch Ophthalmol; 2007 Sep; 125(9):1249-54. PubMed ID: 17846366
    [Abstract] [Full Text] [Related]

  • 3. [Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications].
    Pauleikhoff D, Scheider A, Wiedmann P, Gelisken F, Scholl HP, Roider I, Mohr A, Zlateva G, Xu X.
    Ophthalmologe; 2009 Mar; 106(3):242-51. PubMed ID: 18709375
    [Abstract] [Full Text] [Related]

  • 4. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.
    Pharmacoeconomics; 2008 Mar; 26(1):57-73. PubMed ID: 18088159
    [Abstract] [Full Text] [Related]

  • 5. Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.
    Lotery A, Xu X, Zlatava G, Loftus J.
    Br J Ophthalmol; 2007 Oct; 91(10):1303-7. PubMed ID: 17504847
    [Abstract] [Full Text] [Related]

  • 6. Burden of illness of bilateral neovascular age-related macular degeneration in Spain.
    Ruiz-Moreno JM, Coco RM, García-Arumí J, Xu X, Zlateva G.
    Curr Med Res Opin; 2008 Jul; 24(7):2103-11. PubMed ID: 18547463
    [Abstract] [Full Text] [Related]

  • 7. [Humanistic burden and health resource utilization among neovascular age-related macular degeneration patients in France].
    Soubrane G, Zlateva G, Xu X, Buggage R, Kosa M.
    J Fr Ophtalmol; 2008 Feb; 31(2):138-45. PubMed ID: 18401314
    [Abstract] [Full Text] [Related]

  • 8. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL, Yu F.
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [Abstract] [Full Text] [Related]

  • 9. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
    Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA, Submacular Surgery Trials Research Group.
    Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
    [Abstract] [Full Text] [Related]

  • 10. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.
    Lindblad AS, Clemons TE.
    Arch Ophthalmol; 2005 Sep; 123(9):1207-14. PubMed ID: 16157800
    [Abstract] [Full Text] [Related]

  • 11. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.
    Miskala PH, Hawkins BS, Mangione CM, Bass EB, Bressler NM, Dong LM, Marsh MJ, McCaffrey LD, Submacular Surgery Trials Research Group.
    Arch Ophthalmol; 2003 Apr; 121(4):531-9. PubMed ID: 12695250
    [Abstract] [Full Text] [Related]

  • 12. Investigating the burden of wet macular degeneration.
    Mitchell J.
    Arch Ophthalmol; 2007 Sep; 125(9):1266-8. PubMed ID: 17846369
    [No Abstract] [Full Text] [Related]

  • 13. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.
    Suñer IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM.
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3629-35. PubMed ID: 19255158
    [Abstract] [Full Text] [Related]

  • 14. Age-Related Macular Degeneration and Quality of Life in Latinos: The Los Angeles Latino Eye Study.
    Choudhury F, Varma R, Klein R, Gauderman WJ, Azen SP, McKean-Cowdin R, Los Angeles Latino Eye Study Group.
    JAMA Ophthalmol; 2016 Jun 01; 134(6):683-90. PubMed ID: 27124819
    [Abstract] [Full Text] [Related]

  • 15. Quality of life among patients with age-related severe macular degeneration assessed using the NEI-VFQ, HADS-A, HADS-D and SF-36 tests. A cross-sectional study.
    Inan S, Cetinkaya E, Duman R, Dogan I, Inan UÜ.
    Sao Paulo Med J; 2019 May 08; 137(1):25-32. PubMed ID: 31116266
    [Abstract] [Full Text] [Related]

  • 16. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F, Lafuma A, Berdeaux G.
    Invest Ophthalmol Vis Sci; 2007 Jan 08; 48(1):96-103. PubMed ID: 17197522
    [Abstract] [Full Text] [Related]

  • 17. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
    Fletcher EC, Lade RJ, Adewoyin T, Chong NV.
    Ophthalmology; 2008 Dec 08; 115(12):2192-8. PubMed ID: 18930556
    [Abstract] [Full Text] [Related]

  • 18. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial.
    Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR, MARINA Study Group.
    Arch Ophthalmol; 2007 Nov 08; 125(11):1460-9. PubMed ID: 17998507
    [Abstract] [Full Text] [Related]

  • 19. Vision-related quality of life in patients suffering from age-related macular degeneration.
    Berdeaux GH, Nordmann JP, Colin E, Arnould B.
    Am J Ophthalmol; 2005 Feb 08; 139(2):271-9. PubMed ID: 15733988
    [Abstract] [Full Text] [Related]

  • 20. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
    Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, Fine JT, Bressler NM.
    Invest Ophthalmol Vis Sci; 2011 May 18; 52(6):3354-9. PubMed ID: 21282568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.